Hematology & Oncology Doctors in Bay City, MI Accepting Medicare

2 Hematology & Oncology doctors found. Showing 1 - 2

Dr. Jonathan D Abramson, M. D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3140 W Campus Dr, Bay City, MI 48706 Phone: 989-893-3551    Fax: 989-893-1395

Geetika Kukreja, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3140 W Campus Dr, Bay City, MI 48706 Phone: 989-667-2370    Fax: 989-671-9275

News Archive

President Obama's FY13 budget request increases multilateral global health funding

In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant at CGD, note that while the decreases in funding for the Global Health Initiative (GHI) and PEPFAR in President Obama's FY 2013 budget request are "alarming," the "bright spot" is that multilateral programs, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, would get increases in their funding.

Allscripts Wand now available for EHR users

Allscripts announced the much-anticipated release of Allscripts Wand, which provides users of Allscripts Electronic Health Records a unique, native iPad application that extends the most commonly used functions of Allscripts Professional and Enterprise solutions.

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.

Online searches for 'heart attack' drop during COVID-19, but rise for 'chest pain'

A study of search engine queries addressed the question of whether online searches for chest pain symptoms correlated to reports of fewer people going to the emergency department with acute heart problems during the COVID-19 pandemic.

G8 summit recommendations: Funding and resources for maternal, child health must be increased

Governments and other organizations must intensify efforts to improve the health of women and children, particularly in the developing world where the lion's share of deaths occur, says Dr. Philip Baker, an internationally renowned medical researcher in obstetrics & gynecology. Baker is the lead author on a G8 positioning paper that included consultations with 20 of the world's leading medical experts on women and children's health.

Read more Medical News

› Verified 1 days ago